150 related articles for article (PubMed ID: 15571146)
1. Translational research strategies applied to glioma therapeutics.
Berger MS; Keles GE
Clin Neurosurg; 2004; 51():203-6. PubMed ID: 15571146
[No Abstract] [Full Text] [Related]
2. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.
Haas-Kogan DA; Prados MD; Tihan T; Eberhard DA; Jelluma N; Arvold ND; Baumber R; Lamborn KR; Kapadia A; Malec M; Berger MS; Stokoe D
J Natl Cancer Inst; 2005 Jun; 97(12):880-7. PubMed ID: 15956649
[TBL] [Abstract][Full Text] [Related]
4. PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis.
Wick W; Furnari FB; Naumann U; Cavenee WK; Weller M
Oncogene; 1999 Jul; 18(27):3936-43. PubMed ID: 10435616
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid induces osteopontin via the phosphatidylinositol 3-kinase/Akt pathway to enhance the motility of human glioma cells.
Kim MS; Park MJ; Moon EJ; Kim SJ; Lee CH; Yoo H; Shin SH; Song ES; Lee SH
Cancer Res; 2005 Feb; 65(3):686-91. PubMed ID: 15705860
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas.
Wang H; Wang H; Zhang W; Huang HJ; Liao WS; Fuller GN
Lab Invest; 2004 Aug; 84(8):941-51. PubMed ID: 15184909
[TBL] [Abstract][Full Text] [Related]
7. Pten, a protean tumor suppressor.
Mutter GL
Am J Pathol; 2001 Jun; 158(6):1895-8. PubMed ID: 11395362
[No Abstract] [Full Text] [Related]
8. In vivo gene therapy of human bladder cancer with PTEN suppresses tumor growth, downregulates phosphorylated Akt, and increases sensitivity to doxorubicin.
Tanaka M; Grossman HB
Gene Ther; 2003 Sep; 10(19):1636-42. PubMed ID: 12923562
[TBL] [Abstract][Full Text] [Related]
9. A novel germline mutation of PTEN associated with brain tumours of multiple lineages.
Staal FJ; van der Luijt RB; Baert MR; van Drunen J; van Bakel H; Peters E; de Valk I; van Amstel HK; Taphoorn MJ; Jansen GH; van Veelen CW; Burgering B; Staal GE
Br J Cancer; 2002 May; 86(10):1586-91. PubMed ID: 12085208
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival.
Ermoian RP; Furniss CS; Lamborn KR; Basila D; Berger MS; Gottschalk AR; Nicholas MK; Stokoe D; Haas-Kogan DA
Clin Cancer Res; 2002 May; 8(5):1100-6. PubMed ID: 12006525
[TBL] [Abstract][Full Text] [Related]
11. [PTEN expression in endometrial cancer and the prognosis].
Kanamori Y; Uegaki K; Kigawa J; Terakawa N
Nihon Rinsho; 2004 Oct; 62 Suppl 10():406-9. PubMed ID: 15535277
[No Abstract] [Full Text] [Related]
12. The functional role of tumor suppressor genes in gliomas: clues for future therapeutic strategies.
Fueyo J; Gomez-Manzano C; Yung WK; Kyritsis AP
Neurology; 1998 Nov; 51(5):1250-5. PubMed ID: 9818841
[TBL] [Abstract][Full Text] [Related]
13. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S
Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140
[TBL] [Abstract][Full Text] [Related]
15. Biological mechanisms of glioma invasion and potential therapeutic targets.
Tysnes BB; Mahesparan R
J Neurooncol; 2001 Jun; 53(2):129-47. PubMed ID: 11716066
[TBL] [Abstract][Full Text] [Related]
16. New innovations and developments for glioma treatment.
Croteau D; Mikkelsen T; Rempel SA; Bogler O; Rosenblum M
Clin Neurosurg; 2001; 48():60-81. PubMed ID: 11692657
[No Abstract] [Full Text] [Related]
17. PTEN decreases in vivo vascularization of experimental gliomas in spite of proangiogenic stimuli.
Abe T; Terada K; Wakimoto H; Inoue R; Tyminski E; Bookstein R; Basilion JP; Chiocca EA
Cancer Res; 2003 May; 63(9):2300-5. PubMed ID: 12727853
[TBL] [Abstract][Full Text] [Related]
18. Presence of allelic loss and PTEN mutations in malignant gliomas from Malay patients.
Zainuddin N; Jaafar H; Isa MN; Abdullah JM
Med J Malaysia; 2004 Oct; 59(4):468-79. PubMed ID: 15779579
[TBL] [Abstract][Full Text] [Related]
19. Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.
Shi Y; Gera J; Hu L; Hsu JH; Bookstein R; Li W; Lichtenstein A
Cancer Res; 2002 Sep; 62(17):5027-34. PubMed ID: 12208757
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis.
Gomez-Manzano C; Fueyo J; Jiang H; Glass TL; Lee HY; Hu M; Liu JL; Jasti SL; Liu TJ; Conrad CA; Yung WK
Ann Neurol; 2003 Jan; 53(1):109-17. PubMed ID: 12509854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]